Genome Compiler Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 22

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.4M

  • Investors
  • 1

Genome Compiler General Information

Description

Developer of a DNA design tool designed to help scientists design biological code. The company's DNA design tool helps scientist to edit whole genomes, order syntheses from different providers, collaborate in a secure cloud environment, direct access to algorithms and connection to synthesis and (genetic) construction services, enabling scientists to design, debug and compile the biological code into new living things.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Post Box 3635
  • Los Altos, CA 94024
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Post Box 3635
  • Los Altos, CA 94024
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome Compiler Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 07-Apr-2016 $2.4M Completed Startup
6. Accelerator/Incubator 20-Sep-2015 Completed Startup
5. Early Stage VC 24-Oct-2013 Completed Startup
4. Early Stage VC 01-Jan-2013 Completed Startup
3. Early Stage VC 01-Jan-2012 Completed Startup
2. Early Stage VC 21-Oct-2011 $500K $500K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Genome Compiler’s complete valuation and funding history, request access »

Genome Compiler Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a DNA design tool designed to help scientists design biological code. The company's DNA design tool helps s
Discovery Tools (Healthcare)
Los Altos, CA
22 As of 2016

Santa Fe, NM
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genome Compiler Competitors (23)

One of Genome Compiler’s 23 competitors is OpenEye Scientific Software, a Corporate Backed or Acquired company based in Santa Fe, NM.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OpenEye Scientific Software Corporate Backed or Acquired Santa Fe, NM
Optibrium Private Equity-Backed Cambridge, United Kingdom
Partek Corporate Backed or Acquired Chesterfield, MO
Golden Helix Corporate Backed or Acquired Bozeman, MT
Eurofins Genomics Europe Shared Services Corporation Ebersberg, Germany
You’re viewing 5 of 23 competitors. Get the full list »

Genome Compiler Patents

Genome Compiler Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2751729-A1 System for polynucleotide construct design, visualization and transactions to manufacture the same Active 01-Sep-2011
EP-2751729-A4 System for polynucleotide construct design, visualization and transactions to manufacture the same Active 01-Sep-2011
EP-2751729-B1 System for polynucleotide construct design, visualization and transactions to manufacture the same Inactive 01-Sep-2011
WO-2013030827-A1 System for polynucleotide construct design, visualization and transactions to manufacture the same Inactive 01-Sep-2011
ES-2844529-T3 System for the design, visualization and transactions of polynucleotide constructions to manufacture them Active 01-Sep-2011 G16B25/00
To view Genome Compiler’s complete patent history, request access »

Genome Compiler Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genome Compiler Former Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Autodesk Corporation Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
Angel (individual) Minority
You’re viewing 5 of 25 investors. Get the full list »

Genome Compiler FAQs

  • When was Genome Compiler founded?

    Genome Compiler was founded in 2011.

  • Where is Genome Compiler headquartered?

    Genome Compiler is headquartered in Los Altos, CA.

  • What is the size of Genome Compiler?

    Genome Compiler has 22 total employees.

  • What industry is Genome Compiler in?

    Genome Compiler’s primary industry is Discovery Tools (Healthcare).

  • Is Genome Compiler a private or public company?

    Genome Compiler is a Private company.

  • What is the current valuation of Genome Compiler?

    The current valuation of Genome Compiler is .

  • What is Genome Compiler’s current revenue?

    The current revenue for Genome Compiler is .

  • How much funding has Genome Compiler raised over time?

    Genome Compiler has raised $6.5M.

  • Who are Genome Compiler’s investors?

    Autodesk, , , , and are 5 of 25 investors who have invested in Genome Compiler.

  • Who are Genome Compiler’s competitors?

    OpenEye Scientific Software, Optibrium, Partek, Golden Helix, and Eurofins Genomics Europe Shared Services are some of the 23 competitors of Genome Compiler.

  • When was Genome Compiler acquired?

    Genome Compiler was acquired on 07-Apr-2016.

  • Who acquired Genome Compiler?

    Genome Compiler was acquired by Twist Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process